To examine whether BA could potentiate EGFR-TKIs in lung cancer cells expressing wild-type EGFR gene, we evaluated the inhibitory effect of combination treatment with BA and EGFR-TKIs (gefitinib and osimertinib). This evidence concerns the gene EGFR and lung carcinoma.